T 0734/12 (Arthritis patients with an inadequate response to a TNF-alpha … of 17.5.2013

European Case Law Identifier: ECLI:EP:BA:2013:T073412.20130517
Date of decision: 17 May 2013
Case number: T 0734/12
Application number: 04759142.5
IPC class: A61K 39/395
C07K 16/28
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 222.051K)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor
Applicant name: Genentech, Inc.
Opponent name: Teva Pharmaceutical Industries LTD.
Stada R & D GmbH
Sandoz AG
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 56
European Patent Convention Art 83
European Patent Convention Art 84
European Patent Convention Art 123(2)
European Patent Convention Art 123(3)
Keywords: Added matter, extension of protection (no)
Clarity, sufficiency of disclosure, novelty (yes)
Inventive step (no)


Cited decisions:
G 0002/08
T 0019/86
T 0893/90
T 0298/93
T 0233/96
T 0609/02
T 0986/02
T 1399/04
T 0433/05
Citing decisions:
T 2251/14
T 0321/15

18 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Offical Journal of the EPO

Case Law Book: I Patentability

Case Law Book: IV Divisional Applications

Case Law of the Enlarged Board

General Case Law